Cargando…

Statement of Retraction: Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Statement of Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648400/ https://www.ncbi.nlm.nih.gov/pubmed/36350994 http://dx.doi.org/10.1080/21655979.2022.2143469

Ejemplares similares

Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer
por: Wu, Lipei, et al.
Publicado: (2022)

Statement of Retraction
Publicado: (2012)

Retraction statement
Publicado: (2014)

Statement of Retraction
Publicado: (2020)

Statement of Retraction
Publicado: (2022)

Retraction Statement
Publicado: (2022)

Statement of Retraction. Nuts as a Replacement for Carbohydrates in the Diabetic Diet. Diabetes Care 2011;34:1706–1711. DOI: 10.2337/dc11-0338
por: Jenkins, David J.A., et al.
Publicado: (2016)

Statement of Retraction. Iria Nieto-Vázquez, Sonia Fernández-Veledo, Cristina de Alvaro, and Margarita Lorenzo. Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle. Diabetes 2008;57:3211–3221. https://doi.org/10.2337/db07-1062
Publicado: (2020)

Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455
por: Berglund, Eric D., et al.
Publicado: (2016)

Statement of Retraction. Tub Has a Key Role in Insulin and Leptin Signaling and Action In Vivo in Hypothalamic Nuclei. Diabetes 2013;62:137–148. DOI: 10.2337/db11-1388
por: Prada, Patrícia O., et al.
Publicado: (2017)

Statement of Retraction. Physical Exercise Reduces Circulating Lipopolysaccharide and TLR4 Activation and Improves Insulin Signaling in Tissues of DIO Rats. Diabetes 2011;60:784–796. DOI: 10.2337/db09-1907
por: Oliveira, Alexandre G., et al.
Publicado: (2016)

Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
por: Prada, Patricia O., et al.
Publicado: (2017)

Statement of Retraction. The SNARE Protein SNAP23 and the SNARE-Interacting Protein Munc18c in Human Skeletal Muscle Are Implicated in Insulin Resistance/Type 2 Diabetes. Diabetes 2010;59:1870–1878. DOI: 10.2337/db09-1503. PMID: 20460426
por: Boström, Pontus, et al.
Publicado: (2017)

Statement of Retraction. Gerolama Condorelli, Giovanni Vigliotta, Alessandra Trencia, Maria Alessandra Maitan, Matilde Caruso, Claudia Miele, Francesco Oriente, Stefania Santopietro, Pietro Formisano, and Francesco Beguinot. Protein Kinase C (PKC)-α Activation Inhibits PKC-ζ and Mediates the Action of PED/PEA-15 on Glucose Transport in the L6 Skeletal Muscle Cells. Diabetes 2001;50:1244–1252. DOI: 10.2337/diabetes.50.6.1244. PMID: 11375323
Publicado: (2019)

Statement of Retraction. Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets. Diabetes 2008;57:645–653. DOI: 10.2337/db07-0847; and erratum. Diabetes 2014:63:3974. DOI: 10.2337/db14-er11
por: Shu, Luan, et al.
Publicado: (2017)

Statement of Retraction. Qilong Wang, Zhonglin Xie, Wencheng Zhang, Jun Zhou, Yue Wu, Miao Zhang, Huaiping Zhu, and Ming-Hui Zou. Myeloperoxidase Deletion Prevents High-Fat Diet–Induced Obesity and Insulin Resistance. Diabetes 2014;63:4172–4185. DOI: 10.2337/db14-0026. PMID: 25024373. PMCID: PMC4238009
Publicado: (2021)

Statement of Retraction
Publicado: (2017)

Statement of Retraction
Publicado: (2017)

Statement of Retraction
Publicado: (2021)

Retracted: A Meta-Analysis of the Efficacy of Albumin Paclitaxel versus Docetaxel in the Treatment of Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Statement of Retraction. Francesco Oriente, Salvatore Iovino, Serena Cabaro, Angela Cassese, Elena Longobardi, Claudia Miele, Paola Ungaro, Pietro Formisano, Francesco Blasi, and Francesco Beguinot. Prep1 Controls Insulin Glucoregulatory Function in Liver by Transcriptional Targeting of SHP1 Tyrosine Phosphatase. Diabetes 2011;60:138–147. DOI: 10.2337/db10-0860. PMID: 20864515
Publicado: (2019)

Statement of Retraction. Matilde Caruso, Claudia Miele, Andrea Oliva, Gerolama Condorelli, Francesco Oriente, Gabriele Riccardi, Brunella Capaldo, Francesca Fiory, Domenico Accili, Pietro Formisano, and Francesco Beguinot. The IR(1152) Mutant Insulin Receptor Selectively Impairs Insulin Action in Skeletal Muscle but Not in Liver. Diabetes 2000;49:1194–1202. DOI: 10.2337/diabetes.49.7.1194. PMID: 10909978
Publicado: (2019)

Statement of Retraction. Christopher Lipina, Katherine Macrae, Tamara Suhm, Cora Weigert, Agnieszka Blachnio-Zabielska, Marcin Baranowski, Jan Gorski, Karl Burgess, and Harinder S. Hundal. Mitochondrial Substrate Availability and Its Role in Lipid-Induced Insulin Resistance and Proinflammatory Signaling in Skeletal Muscle. Diabetes 2013;62:3426–3436. DOI: 10.2337/db13-0264. PMID: 23733201. PMCID: PMC3781443
Publicado: (2021)

Statement of Retraction. Christopher Lipina, Clare Stretton, Simon Hastings, Jonathan S. Hundal, Ken Mackie, Andrew J. Irving, and Harinder S. Hundal. Regulation of MAP Kinase–Directed Mitogenic and Protein Kinase B–Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells. Diabetes 2010;59:375–385. DOI: 10.2337/db09-0979. PMID: 19933999. PMCID: PMC2809953
Publicado: (2021)

Statement of Retraction. Lucia Garcia-Guerra, Iria Nieto-Vázquez, Rocio Vila-Bedmar, María Jurado-Pueyo, Guillermo Zalba, Javier Díez, Cristina Murga, Sonia Fernández-Veledo, Federico Mayor, and Margarita Lorenzo. G Protein–Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity. Diabetes 2010;59:2407–2417. https://doi.org/10.2337/db10-0771
Publicado: (2020)

Statement on the safety of d‐ribose
por: Turck, Dominique, et al.
Publicado: (2018)

Statement on the active substance flupyradifurone
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

Statement on the active substance acetamiprid
por: Hernandez Jerez, Antonio, et al.
Publicado: (2022)

ESR Statement on the Validation of Imaging Biomarkers
Publicado: (2020)

ESR statement on portable ultrasound devices
Publicado: (2019)

Statement on non‐dietary exposure on diquat
Publicado: (2018)

Statement on risk mitigation measures on cypermethrin
Publicado: (2019)

ESR statement on the stepwise development of imaging biomarkers
Publicado: (2013)

ESR statement on good scientific practice and publishing
Publicado: (2012)

Position Statement on Indications of Echocardiography in Adults - 2019
por: Barberato, Silvio Henrique, et al.
Publicado: (2019)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
por: Smolen, Josef S, et al.
Publicado: (2013)

Statement for Appropriate Clinical Use of PCSK9 Inhibitors
por: Nohara, Atsushi, et al.
Publicado: (2018)

ESR statement on new approaches to undergraduate teaching in Radiology
Publicado: (2019)

Statement concerning the review of the approval of the active substance ipconazole
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b299b5igbq52cs2pcfvsmitq4u